Yeah.. from the company.
Being private they don't have a set reporting date.
Like the last report... if there is a delay they are probably awaiting some material information.
The FDA required additional trials... then a resubmission... then re processing by the FDA. So, I'd expect that one later in the year.
For me 23 is about how much we can boost our revenue run rate into a cap raise in H2, hence i'm keen to see our forecasted 23 figures. Hopefully Philips' 1000's of sales personnel are trained on NL tech and selling hard.
Fyi - VIZ. AI raised at A$1.8b on circa $20m run rate.
That $13.84 / share equivalent for Nico. Lab.
